The company has not filed an annual or quarterly report since its Q3 FY2022 10-Q, filed Nov 10, 2022. Its latest SEC filing is a 15-12G from Mar 27, 2023.
10-Q for Q3 FY2022, filed Nov 10, 2022
The sections below describe the company as of the FY2021 annual report.
Seeks a merger, acquisition or similar combination with a business, with a stated focus on biotechnology opportunities at the intersection of healthcare and technology.
10-K for FY2021, filed Mar 31, 2022
No revenue was reported.
10-K for FY2021, filed Mar 31, 2022
8-K, filed Mar 8, 2023
On March 8, 2023, Frontier Acquisition Corp. (the “Company”) issued a press release announcing it will redeem all of its outstanding Class…View ↗
Loading...
